Bill Gates – Ursula von der Leyen – Photo © European Union 2023
(BRUSSELS) – The EU, European Investment Bank and Bill & Melinda Gates Foundation announced Wednesday a new financing partnership to eradicate polio and ensure health innovations are accessible to those who need them most.
The World Health Organization and UNICEF, as implementing partners for the polio funding, will deploy the resources to eradicate polio, support the distribution of other childhood immunizations and strengthen health systems so they are better able to respond to emerging health threats.
The expected 1.1 billion financing package aims to provide new funding to eradicate a human disease for only the second time in history and help solve the health and development challenges faced by the world’s most vulnerable people, who otherwise do not get fair access to healthcare services and innovations.
The partnership marks a significant increase in funding for global health and human development under the European Commission’s European Fund for Sustainable Development plus (EFSD+) and is expected to include a match of new complementary funding for global health by the Bill & Melinda Gates Foundation, maximising the impact of every Euro committed by the EU and the European Investment Bank.
To promote swift progress towards eradicating wild poliovirus, the partnership aims to deliver 500 million in payments to the Global Polio Eradication Initiative specifically the World Health Organization and UNICEF. The funds will cover polio vaccinations for nearly 370 million children annually; deliver vital health services to children alongside polio campaigns, including measles vaccines and other routine immunizations; and strengthen health systems to better prepare and respond to emerging health threats, as the polio program has done against COVID-19, Ebola, and other diseases. Today, wild poliovirus remains endemic in just two countries Pakistan and Afghanistan and 80% of variant poliovirus cases are found in just four subnational regions.
“Thanks to medical innovations, the world eradicated one human disease smallpox. Today we’re on the verge of ending another wild poliovirus. I am committed to ensuring that no child, anywhere in the world, faces this awful disease. I am also optimistic that we will eradicate polio once and for all and make health innovations more accessible for everyone, particularly those in the poorest countries,” said Bill Gates, co-chair of the Bill & Melinda Gates Foundation.
Another 500 million aims to expand the innovation capacity of health systems in low- and middle-income countries. This includes new funding to initiatives supported by the European Commission such as efforts to make health innovations like mRNA-based vaccines and therapeutics more accessible to people in low- and middle-income countries, under Europe’s investment plan for the world, Global Gateway. More investments in health worldwide will be discussed among global leaders and partners at the upcoming Global Gateway Forum (25-26 October)
Specifically, the funding partnership is expected to include:
- 500 million in new funding for the Global Polio Eradication Initiative (as outlined above)
- 500 million in investments and grants to ensure health innovations are more accessible, strengthen health systems and prepare for future pandemics: The Bill & Melinda Gates Foundation plans to provide 250 million of grants and investments to match a 250 million in investments made by the European Investment Bank and guaranteed by the European Fund for Sustainable Development plus.
- 80 million grants for Technical Assistance: The Bill & Melinda Gates Foundation expects to match 40 million in grants from the European Commission to provide technical assistance and ensure that global health programs achieve their full potential.
The partnership announced today builds from existing partnerships between the Bill & Melinda Gates Foundation and the European Commission and Member States, including a EUR 100 million support package for the recently established African Medicines Agency (AMA) and national African medicines regulatory agencies or regional initiatives, the African Health Diagnostics Platform, which supports African partners to increase access and reduce costs of laboratory testing, and coordination on health initiatives such as COVAX, a global collaboration to accelerate the development, production, and equitable access to COVID-19 tests, treatments, and vaccines.
